Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

83.3%

5 terminated/withdrawn out of 6 trials

Success Rate

16.7%

-69.8% vs industry average

Late-Stage Pipeline

33%

2 trials in Phase 3/4

Results Transparency

100%

1 of 1 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

Phase 4

1(33.3%)

N/A

1(33.3%)

Phase 3

1(33.3%)

3Total

Phase 4(1)

N/A(1)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials

NCT01379989Phase 3Completed

INOVATYON STUDY -International, Randomized Study in Patients With Ovarian Cancer

Role: collaborator

NCT01308996Not ApplicableWithdrawn

Clinical Study of INFUSE® Bone Graft Compared to Autogenous Bone Graft for Vertical Ridge Augmentation

Role: collaborator

NCT00209417Phase 4Terminated

Renal Effects of Two Iodinated Contrast Media in Patients at Risk Undergoing Computed Tomography

Role: collaborator

NCT00991393Terminated

Sinus Augmentation With Dental Implant

Role: collaborator

NCT00991965Terminated

Localized Alveolar Ridge Augmentation With Dental Implant

Role: collaborator

NCT00991432Terminated

Localized Alveolar Ridge Augmentation With Space Maintenance Devices

Role: collaborator

All 6 trials loaded